Table 1 Baseline covariates in the ADAPT study
Baseline covariate | Omalizumab N = 30 | Placebo N = 30 | Total N = 60 |
|---|---|---|---|
Age: < 10 yrs | 14 (47%) | 15 (50%) | 29 (48%) |
≥10 yrs | 16 (53%) | 15 (50%) | 31 (52%) |
Total IgE: ≤1500 | 1 (3%) | 2 (7%) | 3 (5%) |
> 1500 | 29 (97%) | 28 (93%) | 57 (95%) |
Total IgE (kU/l) | 8110.5 (4556.0, 22,122.0) | 8372 (4461.0, 16,200.0) | 8321 (4508.5, 19,425.0) |
Total SCORAD | 69.5 (10.7) | 69.5 (9.2) | 69.5 (9.9) |
EASI | 45.5 (10.1) | 43.4 (11.3) | 44.4 (10.7) |
(C)DLQI | 17 (5.6) | 17.2 (4.4) | 17.1 (5.0) |